Boehringer Ingelheim | Sustainability Performance
A global healthcare company engaged in the research, development, and manufacturing of pharmaceuticals. It operates in various therapeutic areas, focusing on innovative treatments and animal health products to meet diverse medical needs.
1885
Germany
10,001+ employees
Pharmaceuticals
$100M - 500M in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#10043
Overallⓘ#462
in Germanyⓘ#240
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon certificatesGovernance
Targets
Controversy level
- Boehringer Ingelheim paid over USD 650 million settling thousands of Pradaxa bleeding death lawsuits in the US.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.